---

Congratulations to Dr. Wu-Min Deng, a recipient of a 2024 Ladies Leukemia League Grant, to fund the research project, “Targeting NKCC Dysregulation: A Therapeutic Approach for Ascites Management in Leukemia Patients,” to be awarded April 2024.
 

---

From Tulane News - Infections from these bacteria are on the rise. New blood test cuts diagnosis time from months to hours (featuring Dr. Bo Ning): https://news.tulane.edu/pr/infections-these-bacteria-are-rise-new-blood-test-cuts-diagnosis-time-months-hours

---

Congratulations to Dr. William Wimley and Team

Ferrie, R.P., Fuselier, T., and Wimley, W.C. (2024) Cytosolic Delivery of Bioactive Cyclic Peptide Cargo by Spontaneous Membrane Translocating Peptides. ACS Omega  https://doi.org/10.1021/acsomega.3c08701

---

Tulane Receives $1.6 Million to Develop Nanoscale Drug Delivery

Creating holes in a cell is usually a bad thing, but researchers at Tulane have received a grant to study how they might create controlled nanopores as small as a molecule to deliver targeted medicine into cells.  

Bill Wimley, the George A. Adrouny, PhD Professor in Biochemistry in the Department of Biochemistry and Molecular Biology in the Tulane School of Medicine, has been awarded a grant of $1.6 million from the National Institute of General Medical Studies to study nanopore technology.  

This research uses a compound derived from melittin, a main component of honeybee venom, to make small pores in membranes. These pores are on the nanometer scale, hence the name “nanopores.”  

“This peptide, melittin, it permeabilizes membranes and causes nonspecific damage to cells that way,” said Wimley, “so we took melittin and evolved it over multiple generations into peptides that are controllable, more useful and less toxic.” 

These evolved peptides, which are short chains of amino acids, are not controlled by a remote or any electronics but by the pH, or acidity, of their environment. One family of these nanopore-forming peptides is triggered by an acidic environment.  

“They are designed not to affect cells under normal conditions,” Wimley said.  

They are triggered when endosomes, which take up material from the outside of cells, mature and acidify. It is only in that acidic environment that the peptides form nanopores in the cell membrane.  

Nanopores allow for macromolecules, molecules too large to move through cell membranes under normal circumstances, to have a way into cells. This research could lead to breakthroughs in medicine delivery. This current grant, however, is looking at the more basic structural level of understanding of the technology. As Wimley put it, “What drives these very unusual nanopores to form in membranes?”  

In order to learn more about these nanopores, Wimley and his team will start with computer simulations of their evolved peptides, then they will move toward laboratory testing in order to see what makes the peptides behave the way they do. Once they understand that, then more research can be done into potential life-saving applications.   

The patent for this nanopore technology is shared between Tulane and Johns Hopkins University. Wimley will be working on this research with an international team that includes researchers in Romania and at Johns Hopkins.

---

SAVE THE DATE - 2024 George Adrouny Memorial Lecture, Tuesday, April 23^rd

 

The 2024 featured speaker is Lila M. Gierasch, PhD, Distinguished Professor in the Departments of Biochemistry & Molecular Biology and Chemistry at the University of Massachusetts Amherst. 

Dr. Gierasch is a biophysical chemist recognized for her work on protein folding, with particular emphasis on in vivo folding and roles of molecular chaperones. Born in Massachusetts, Gierasch graduated from Mount Holyoke College in 1970 with a degree in chemistry and obtained her Ph.D. in Biophysics from Harvard University in 1975. She held faculty positions at Amherst College, the University of Delaware, and the University of Texas Southwestern Medical School prior to joining the University of Massachusetts Amherst where she is currently Distinguished Professor of Biochemistry & Molecular Biology and Chemistry. In 2006, she received a NIH Director's Pioneer Award. Among her other honors are Sloan and Guggenheim Fellowships, the Vincent du Vigneaud and Merrifield Awards of the American Peptide Society, a D.Sc. Honoris Causa from Mount Holyoke College, the Garvan-Olin Medal and Ralph Hirschmann Award of the American Chemical Society, the Dorothy Hodgkin Award of the Protein Society, and the Mildred Cohn Award of the American Society of Biochemistry & Molecular Biology. Gierasch is Editor-in-Chief of the Journal of Biological Chemistry, a past President and a Fellow of the Biophysical Society, and a member of both the American Academy of Arts and Sciences and the National Academy of Sciences. 

The Gierasch's Laboratory has made fundamental contributions to the relationship between amino acid sequence and the preferred conformations of peptides and proteins. Her work shed light on turn propensities in proteins and offered a basis for design of analogues of bioactive peptides. Her lab has addressed protein folding in cells, developing tools to study the fate of newly synthesized proteins, including their proper folding and cellular localization. Her lab elucidated conformational propensities and physical properties of signal sequences, which helps to explain how diverse sequences can target a polypeptide chain to the secretory pathway. Gierasch and coworkers were involved in studies that demonstrated the roles of molecular chaperones, a network of species that protect incompletely folded proteins in the cell from aggregation and misfolding. Her lab described how molecular chaperones recognize 'unfoldedness' in their protein substrates, showing that chaperonins like GroEL exploit hydrophobic surfaces to recognize substrates, while Hsp70s bind polypeptides as extended chains. Recently, Lila Gierasch's laboratory has unraveled the allosteric mechanism of Hsp70 chaperones, which are central hubs in protein homeostasis and quality control. The work of her laboratory provides insights into the pathologies that arise from mistakes in protein folding, such as the neurodegenerative diseases.

Additional details may be requested from Kelly Ragland Boyd at kraglan@tulane.edu.

 

---

Congratulations to Tania Antoshchenko and Welcome to Alexa Dow Sturtz in the SIF! 

After 11 years in the department, with the last 5 years serving as the Shared Instrumentation Facility (SIF) Manager, Tania Antoshchenko has embarked on a new professional journey as the Assistant Director of OEHS. We express our deepest gratitude to Tania for her unwavering dedication, leadership, and the countless contributions she has made to our department. We wish her the very best in her new role.

On the flipside, we are pleased to announce that Tania's successor is a familiar face to many of us – Alexa Dow Sturtz. Alexa is no stranger to our department, having graduated from our Master’s Program in 2018. Over the past 5 years, she has been an integral part of Dr. Heather Machado’s lab.  We are glad to welcome Alexa as she steps into the role of SIF Manager. Her experience, knowledge, and familiarity with our department will contribute to the continued success of the SIF.  Alexa is a Louisiana native, having grown up in Baton Rouge. She moved to New Orleans in 2018 after completing her master’s degree. Shortly thereafter, she met her husband, Joseph, a two-time Tulane alum. They were married in May 2022 and welcomed their son, Andersen, in March of 2023. When not in the SIF, you can find Alexa cheering on the Green Wave football team or organizing community events both at Tulane and in the greater New Orleans area. She is an active member of the Junior League of New Orleans, President-Elect of the Tulane University Women’s Association, and a dedicated Room Parent and parishioner of St. Louis King of France in Bucktown. 

To contact Alexa on matters related to the Shared Instrumentation Facility, please contact her at 504.988-7165 or biosif@tulane.edu for assistance.

 

 

---

Faculty News - Spring 2023

Ivana Celic

Attended the Global Consortium for Reproductive Longevity & Equality (GCRLE) Symposium, Novato, California, February 3rd

Wu-Min Deng

Attended the Annual Drosophila Research Conference, Chicago, Illinois, March 1st

Attended Polyploidy 2023, Palm Coast, Florida, May 9th

Jia Fan

Attended the 19th Annual US HUPO Conference, Chicago, Illinois, March 4th

David Franklin

Attended the Annual Association of Medical and Graduate Departments of Biochemistry (AMGDB) Meeting, Clearwater, Florida, January 12th

Attended the Association of Biochemistry Educators Conference, Kiawah, South Carolina, April 30t

Tony Hu

Attended the Keystone Symposium, Banff, Canada, February 19t

Invited speaker at the Pittcon Conference and Exposition/Induction into the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows, Philadelphia, Pennsylvania, and Washington, DC, respectively, March 19th and March 27t

Speaker at the Association for Mass Spectrometry & Advances in the Clinical Lab (MSACL) Conference, Monterey, California, April 5t

Jun-yuan Ji

Invited seminar by the University of Connecticut, Storrs, Connecticut, April 4t

Invited seminar by Albert Einstein College of Medicine (Department of Medicine and Michael F. Price Center), New York, New York, March 31st

Samuel Landry

SeroNet Annual Meeting, Bethesda, Maryland, March 21st

Hua Lu

Attended the Annual Association of Medical and Graduate Departments of Biochemistry (AMGDB) Meeting, Clearwater, Florida, January 12t

James Jackson

Conference talk, Cold Spring Harbor Laboratories (Banbury), Lloyd Harbor, New York, January 23rd

Tianhua “Tim” Niu

January-March 2023 contributed to editorial review services for the following journals: (1) Metabolites (MDPI) (1 paper, reviewer comments provided to authors, the paper has been revised and resubmitted, which is under review); (2) Frontiers in Immunology (1 paper, reviewer comments provided to authors and Journal Editor); (3) Antioxidants (MDPI) (1 paper, reviewer comments provided to authors, and the paper is currently being revised).

Zachary Pursell

Participated in the Keystone Symposia on Genomic Instability and DNA Repair, Whistler, British Columbia, Canada, March 19th

William Wimley

Attended the Annual Biophyscial Society Meeting (BPS 2023), San Diego, California, February 18th

Attended the National American Physical Society (APS) Meeting, Las Vegas, Nevada, March 5th

---

BRIMR Ranks Tulane’s Department of Biochemistry and Molecular Biology 30th in NIH Funding in 2022

The Blue Ridge Institute for Medical Research’s yearly rankings for 2022 show that the Tulane School of Medicine’s Department of Biochemistry and Molecular Biology ranked 30th out of 96 medical schools, with $9.5 million in National Institutes of Health (NIH) funding, sitting between Stanford (29th) and UCLA (31st).  This statistic was mentioned during the Dean’s Town Hall Meeting on February 14th.

The data, as compiled by Robert Roskoski Jr. and Tristram G. Parslow, also showed Tulane as a whole currently ranks 61st in NIH funding, with $73 million when compared to 144 Medical Schools, standing between Thomas Jefferson University (60th) and the University of Cincinnati (62nd).

The BRIMR rankings are derived from NIH’s year-end composite data for the federal fiscal year ending September 30th, 2022, as released on the National Institutes of Health’s Research Portfolio Online Reporting Tool.  The data was posted in late December 2022. It contained tabulated information on more than $36 billion in funding through 65,307 extramural NIH grants or contracts awarded to more than 43,500 Principal Investigators (PIs) that year.

Every year since 2006, the Blue Ridge Institute for Medical Research (BRIMR), an independent nonprofit organization, has published rankings of institutions, departments, and investigators based on the funding they receive from the NIH. The BRIMR standings are widely cited as a measure of scientific vitality, and have been used to examine trends in funding to individual grantees and to academic specialties.

Compilers of these statistics are Robert Roskoski Jr., the Scientific Director and President of the Blue Ridge Institute for Medical Research, and Dr. Tristram G. Parslow, a pathologist in Atlanta, Georgia, affiliated with Emory University Hospital.

More information may be found at https://brimr.org/brimr-rankings-of-nih-funding-in-2022/.

---

Congratulations to Kalen Hall (Lisa Morici Lab) and Leonard Williams (Zachary Pursell Lab), recipients of the Provost’s Proof of Concept Fund, for their project, “A precision diagnostic for antibiotic resistance using machine learning.”  (More information coming.)

---

Congratulations to Dr. William Wimley

2023-24 grant recipient from the Ladies Leukemia League of the Gulf South, for his research project, "Understanding the Biology of TP53 Mutations in Acute Myeloid Leukemia."

---

Tony Hu Inducted into the 2023 Class of the AIMBE College of Fellows 

(From AIMBE Press Release)
 

WASHINGTON, D.C.— The American Institute for Medical and Biological Engineering (AIMBE) has announced the induction of Tony Y. Hu, Ph.D., Professor, Director and Presidential Chair in Biotechnology Innovation at Tulane University to its College of Fellows. 

Election to the AIMBE College of Fellows is among the highest professional distinctions accorded to a medical and biological engineer. The College of Fellows is comprised of the top two percent of medical and biological engineers. College membership honors those who have made outstanding contributions to "engineering and medicine research, practice, or education” and to "the pioneering of new and developing fields of technology, making major advancements in traditional fields of medical and biological engineering or developing/implementing innovative approaches to bioengineering education." 

Dr. Hu was nominated, reviewed, and elected by peers and members of the College of Fellows “for his outstanding contributions to disease diagnostics by developing nanomaterial-based tools to facilitate translational studies for critical global health initiatives.” 

A formal induction ceremony was held during the AIMBE Annual Event at the Renaissance Arlington Capital View Hotel in Arlington, Virginia on March 27, 2023. Dr. Hu was inducted along with 140 colleagues who make up the AIMBE College of Fellows Class of 2023. 

While most AIMBE Fellows hail from the United States, the College of Fellows has inducted Fellows representing 30 countries. AIMBE Fellows are employed in academia, industry, clinical practice and government. 

AIMBE Fellows are among the most distinguished medical and biological engineers including 3 Nobel Prize laureates, 17 Fellows having received the Presidential Medal of Science and/or Technology and Innovation, and 205 also inducted to the National Academy of Engineering, 105 inducted to the National Academy of Medicine and 43 inducted to the National Academy of Sciences. 

---

Tony Hu invested as a Tulane Weatherhead Presidential ChairTony Hu invested as a Tulane Weatherhead Presidential Chair:  Read about this exciting news HERE.

 

---

Congratulations to Dr. Samuel Landry, recipient of a Tulane SOM Pilot Funding project entitled “MHCII pathway processing of SARS-CoV-2 spike," January 2023.

---

SAVE THE DATE -
April 18th, 2023 George A. Adrouny Memorial Lectureship.

Speaker:  Lieping Chen, MD, PhD United Technologies Corporation 
Professor in Cancer Research and Professor of Immunobiology,
of Dermatology and of Medicine (Medical Oncology)
Yale School of Medicine
West Haven, Connecticut
More details to come

---

Posted position for the Assistant Faculty Position: http://apply.interfolio.com/111781

 

---

BMS Leadership Announcement (Sept. 16, 2022) 

The School of Medicine (SOM) is pleased to announce the addition of Drs. Heather Machado and Derek Pociask to the leadership team overseeing the Biomedical Sciences (BMS) Graduate Program at Tulane SOM together with the Associate Dean for BMS, Dr. Robert Garry.       

Heather L. Machado, PhD, has accepted the position of Assistant Dean for Biomedical Sciences Graduate Program at Tulane School of Medicine. Dr. Machado will oversee Curriculum and Compliance for the graduate program, coordinate Student Affairs, Finance and Accreditation, and enhance opportunities to further the development and diversity of graduate students in the program. Dr. Machado will also work collaboratively with the Director of Graduate Education to coordinate BMS Admissions and to build new NIH-funded programs to support students and faculty.     

Dr. Machado is Associate Professor of Biochemistry and Molecular Biology and a program member of the Tulane Cancer Center and Louisiana Cancer Research Consortium. After earning her PhD at Tulane School of Medicine in 2005, she completed her postdoctoral training at Baylor College of Medicine in Mammary Gland and Breast Cancer Biology. Since opening her laboratory at Tulane in 2013, she has maintained an active research program that has been continuously funded by NIH and other extramural funds. She has been actively engaged in the BMS PhD program, teaching several courses to PhD, MS and MD students, serving on numerous student and faculty committees, as Chair of the BMS Admissions Committee, and directing the ASPIRE and ASPIRE Buddy research programs. In the past 10 years, she has trained numerous MS, MD and BS students, and mentored 7 PhD students.
 

---

Congratulations to Dr. Heather Machado, recipient of an NIH R01 award, “Functions of ductal- and stromal-associated macrophages in the mammary gland,” 09-07-2022 – 07-31-2027.

---

Congratulations to Dr. Wu-Min Deng and Team, NIH R01, Notch signaling and germline-soma interactions in the Drosophila ovarian model, 9/1/2022-5/31/2026.

---

Congratulations to Dr. Tony Hu and Team, NIH R21, Quantification of brain-derived extracellular vesicle microRNAs in blood by a liposome-mediated CRISPR assay for traumatic brain injury detection,  9/1/2022 – 8/31/2024.

---

From Inside Tulane (Dr. Jia Fan):  "Researcher awarded Intelligence-driven mass spectrometry system from NIH grant," July 19th, 2022, 5:15 PM

---

New Journal Article from Dr. Tony Hu and Team:  "Diagnosis of paediatric tuberculosis by optically detecting two virulence factors on extracellular vesicles in blood samples,” Nature Biomedical Engineering, August 2022

---

Congratulations to Dr. Aiguo Tian, on publication of his new article, “Damage-induced regeneration of the intestinal stem cell pool through enteroblast mitosis in the Drosophila midgut,” The EMBO Journal, August 2022
 

---

Congratulations to Dr. Hua Lu and Team, new NIH R21, “Validating p53 Ser46 crotonylation as a potential target for possible anti-cancer therapy,” starting July 26th, 2022.

---

WELCOME Dr. Michelle Matter, Professor, the newest member of our faculty, beginning August 1st, 2022.

---

Congratulations to Drs. Jia Fan and Tony  Hu, recipients of an NIH S10 award, “Acquisition of next-generation Orbitrap Eclipse Tribrid Mass Spectrometer system,” 07/01/2022 – 06/30/2023
 

---

Congratulations to Dr. Tony Hu, recipient of an NIH R01 award, “A nanopore biosensor for leveling Mtb antigens in blood,” 06/15/2022 – 05/31/2027
 

---

Congratulations to Dr. Bo Ning, recipient of an NIH R21, “Liposome fusion enabled extracellular vesicle detection for COVID-19,” beginning 6/1/22
 

---

Congratulations to Haoyang Liang in winning the 2022 Quoc Le Award! 

The Department of Biochemistry and Molecular Biology is pleased to announce that this year’s recipient of the Annual Quoc C. Le, MD, PhD Memorial Award is Haoyang Liang. 

Haoyang recently completed his first year of medical school here at Tulane. He received his bachelor’s degree in Biotechnology from Zhengzhou University in China and a master’s diploma in Immunology from King’s College London. Since undergrad, he has participated in a series of tumor immunology research activities for the past six years in different research institutes in the USA, the UK, and China. Currently, he is a member of Dr. Lu’s Lab in the Biochemistry and Molecular Biology Department of the Med School. In addition to PhD research, his focus is on exploring the novel mechanisms of cancer tumorigenesis and underlying genetic factors in cancer metabolism at a biomolecular level. 

Haoyang is honored to be the recipient of this year’s Award.

---

A MILESTONE – A hybrid event made the 20th Annual George Adrouny Memorial Lectureship a unique event for this two decade anniversary.  A great in-person and virtual audience enjoyed a superb seminar given by Dr. Danny Reinberg, PhD, held in person on Friday, April 22nd at the Tidewater Gallery and Auditorium at 1440 Canal Street in New Orleans.  The event began at 10:00am with an introduction by the George A. Adrouny Professor of Biochemistry and Molecular Biology Dr. William Wimley, followed by the presentation of the George A. Adrouny Award for Outstanding Achievement in Medical Biochemistry, presented to Medical student Brianne Feta (Masters student Bryce Jensen was presented his award post Lecture).  Department Chair Dr. Hua Lu introduced the speaker and Dr. Melissa Adrouny spoke on behalf of the Adrouny Family.

For additional information on this year's event, please contact Gilbert Estrada for a copy of our Spring 2022 BioNotes.

---

Reprinted from the Tulane Cancer Center eNewsletter Inroads (April 2022)

Researcher Awarded $2 Million NIGMS Grant to Study Biology of "Jumping Genes"

Jeffrey Han, MD, PhD, and his team aim to better understand how DNA damage caused by the transposon L1 causes infertility in a mouse model. A better understanding of the biology of L1 could also help researchers make connections to other diseases associated with transposon activity, including cancer.

Transposons – also known as "jumping genes" – are pieces of movable DNA that can jump around in the genome. Through a cut-and-paste or copy-and-paste mechanism, they can move copies of themselves to a different chromosome or to a different area of the same chromosome. This process – called transposition – can result in mutations and DNA damage......Read More

---

Congratulations to Dr. Diane A. Blake for a Successful 30 years at Tulane - To be Emeritus Professor July 1, 2022 

Diane A. Blake, PhD, Professor of Biochemistry and Co-Director of the Graduate Program in Biomedical Sciences, will be retiring from Tulane University School of Medicine effective July 1, 2022, after 30 years of service. During that time, she rose through the ranks to full professor, ran an active research program, published more than 115 scientific papers, and trained 13 PhDs and 11 postdoctoral fellows.     

In 2015, she was named Co-Director of the Graduate Program in Biomedical Sciences. During Dr. Blake’s 7 years in this position, she played a critical role in helping to create a vibrant and academically excellent interdisciplinary graduate program. The PhD program currently enrolls >130 students and the 16 distinct MS programs prepare ~200 students/year for entrance into professional school or careers in academic or industrial research.  She has served in several other important roles including as a member of the Professionalism TRIO committee, Director of the ASPIRE Summer Research Program for Rising T2 Medical Students and Co-Director of the ASPIRE Research Buddy Program for Undergrad Students of Color, Chair of the Medical School Research Committee for the LCME, and Principal Investigator for Tulane on the BOR (Broadening Experiences in Scientific Training for STEM Graduate Students) Comprehensive Enhancement Grant.

We are indebted to Dr. Blake for her outstanding service to the school. 

---

Congratulations to Dr. James Jackson, new funding, NIH R01, “Targeting mechanisms of immune evasion in chemotherapy-induced senescent cells,” 04/19/2022 – 02/28/2027.

---

20th Annual George Adrouny Lecture and the History of the Adrouny Memorial Lectureship, Friday, April 22^nd, 2022 

The 2022 featured speaker is Danny Reinberg, PHD, Terry and Mel Karmazin Professor of Biochemistry and Molecular Pharmacology, in the Department of Biochemistry and Molecular Pharmacology at New York University School of Medicine.  Dr. Reinberg’s research focuses on such areas as transcription factors, genetic transcription, histones, RNA Polymerase II, and Chromatin.  Reinberg was born in Santiago, Chile in 1954. Reinberg's higher education includes the Catholic University in Valparaiso, Chile.
Click to read more about Dr. Reinberg's work.

---

 

---

INNOVATION - Dr. Tony Hu featured in the Winter 2022 issue of The Tulanian.

---

Congratulations to Dr. Bo Ning, promotion to Assistant Professor with tenure in the Department of Biochemistry and Molecular Biology, effective January 1st, 2022.

 

 

---

SAVE THE DATE - FRIDAY, APRIL 22, 2022
George A Adrouny Memorial Lectureship
10:00am US Daylight Savings Time
In person an via Zoom

Danny Reinberg, PhD
Terry and Mel Karmazin Professor of Biochemistry and Molecular Pharmacology
New York University of Medicine
New York, New York

More information coming.  For the latest, contact Kelly Ragland Boyd at kraglan@tulane.edu

---

Li named National Academy of Inventors Fellow

Chenzhong Li, professor of biomedical engineering and biochemistry at the School of Medicine and the School of Science and Engineering, has been named a 2021 fellow by the National Academy of Inventors.  Read about this honor.

(1/5/22)

---

$3.1 Million NCI Grant Supports Development of Potential Blood Test for Pancreatic Cancer

Read more about Dr. Tony Hu in the Tulane Cancer Center News.

(12/17/21)

---

Masters Students
Fall/Spring 2021/22

---

7th Annual Scientific Departmental (Virtual) Retreat
August 13, 2021

---

August 5th, 2021 Tulane News features Dr. Tony Hu ("Tulane researchers design nanotechnology blood test to find hidden COVID-19 infections"):

Article from Tulane News

---

Important new Nature nano paper from Dr. Tony Hu and Team, published online:

https://www.nature.com/articles/s41565-021-00939-8

---

Career Conversations:

Q&A with Molecular Biologist Hong Liu – Biomedical Beat Blog – National Institute of General Medical Sciences -- Click Here

---

Congratulations to Scout Treadwell in winning the Quoc Le Award!

Scout Treadwell has completed her first year of medical school at Tulane University School of Medicine. She serves as a Representative on the Tulane School of Medicine Honor Board. In 2020, she graduated Magna Cum Laude from the University of Mississippi with a Bachelor of Arts degree in biochemistry. Throughout her undergraduate career, she completed her thesis on the Effects of Alpha Tocopherol and Ascorbic Acid on Metastatic Breast Cancer. This Summer, Scout is continuing her breast cancer research as a member of the Machado Lab, where she will study the role of the gene AXL in breast cancer. With a history of breast cancer on both sides of her family, this is a particularly personal area of research for Scout. She is interested in the fields of Hematology, Oncology and Dermatology.

Born and raised in Dadeville, Alabama, she now calls New Orleans her home. She has strengthened her ties with her community by volunteering at the Salvation Army Tuberculosis Clinic, Grace House Preceptor Clinic, serves as the clinic leader at the New Orleans Mission and has built for Habitat for Humanity. Her hobbies include cooking, baking and running. She completed the Great 38 Race in Oxford, Mississippi, and is training for 2022 Rock ‘n’ Roll Half Marathon in New Orleans. She also enjoys traveling with her family.
 
Scout is honored to be recipient of the Annual Quoc C. Le, MD, PhD Memorial Award. She is eager to work with the our department to collect and analyze data that will advance the scientific efforts to cure cancer.

---

ASPIRE Summer Research Buddy Program, 2021

In collaboration with the Newcomb-Tulane College’s Office of Academic Enrichment, Tulane School of Medicine has developed a new outreach program for Summer 2021 to specifically address the underrepresentation of students of color in the medical field. The ASPIRE Summer Research Buddies will assist medical students conducting research in the ASPIRE program, and will also provide our medical students with supervisory experience. The program funds three talented Tulane undergraduates, who are paired with a current medical student/mentor from this year’s ASPIRE program.

Dr. Lu and his lab were matched this year with Adhithi Sreenivasan. She is interested in the relationship of cancer to neurobiology.  As a rising sophomore, Adhithi will receive lab-based experience while assisting 2nd year medical student Alyssa Webster. We are confident that both students will benefit from this program through mentorship, collaboration, and research exposure.
 
Congratulations to Adhithi, and we look forward to seeing her in the halls of the department.

---

New Grant Funding in the Department

First Half of 2021
Any new funding not reported here will be provided in our next update

• James Jackson (NIH R01) Genotoxic Stress Response and Mutagenesis in Normal Tissues of Mice Deficient in Homology Directed Repair, April 2021-January 2026
• Jun-Yuan Ji (Mike Slive Foundation) Functions of the CDK8 Module in Prostate Cancer Cells, March 2021-March 2022
• Jun-Yuan Ji (NIH R01) Role of alpha-catenin and Wnt signaling in regulating lipid homeostasis, March 2021-August 2022
• Jun-Yuan Ji (NIH R01) Role of alpha-catenin and Wnt signaling in regulating lipid homeostasis (Supplement), March 2021-August 2022
• Jun-Yuan Ji (NIH R01) Context-specific Functions of CDK8, March 2021-Januray 2024
• Hong Liu (NIH R01) Functions and Regulation of Centromeric Transcription, May 2021-April 2025
• Christopher Lyon (NIH) Mtb and HIV/SIV antigen peptide signatures as blood biomarkers to detect early infection to active disease in young children and NHP (Sub award), May 2021-March 2026
• Christopher Lyon (NIH) Direct quantitation of the circulating Mtb-peptidome for pediatric TB management, March 2021-February 2022
• Aiguo Tian (NIH) Mentoring Research Excellence in Aging and Regenerative Medicine COBRE - Admin Core, January 2021-May 2021
• Aiguo Tian (NIH) Mentoring Research Excellence in Aging and Regenerative Medicine COBRE - Admin Core, June 2021-May 2022
• William Wimley (NIH R21) Mechanism of Resistance Avoidance in Synthetically Evolved Antibacterial Peptides, June 2021-May 2023
• Yiwei Zhang (School of Medicine Pilot Funds) Role of p53-IMP2 axis in adipocyte browning, March 2021

---

Other Faculty News

Heather Machado

Grant Submissions
1R21HD102657-01  Stromal regulation of mammary gland ECM homeostasis during pregnancy (June 2022).
1R01HD106929-01  Functions of ductal- and stromal-associated macrophages in the mammary gland (Feb. 2022).

William Wimley

Grant Submissions
Collabborative R21 proposal to NIGMS
STTR/R41 proposal to NIAID
Note:  Submitted two pre-proposals to the Department of Defense Peer Reviewed Medical Research Program 2021.
Grant reviewer
Continued service on the Biochemistry/Biophysics fellowship (F30,F31,F32) panel for NIH.
Seminars
Invited speaker at the virtual Spring Meeting of the American Chemical Society.
Service
Editorial Board Member: BBA-Biomembranes and Journal of Membrane Biology.

Hua Lu

Invited talks
Invited distinguished seminar online, 100th Anniversary of Nanchang University-Jiangxi School of Medicine, Nanchang, Jiangxi Province, China (May 2021).
Department of Cancer Biology, University of Toledo School of Medicine, Toledo, OH, USA (May 2021).
Department of Integrative Biology and Pharmacology, UT Health McGovern School of Medicine, Houston, TX 77030, USA (April 2021).
JMCB, Associate Editor; Topic Editor, Frontiers in Cell and Developmental Biology (open access), 2021-2022.3; Associate Editor, Genes & Diseases, Elsevier B.V. press. 2019-present; Ad hoc reviewers for more than 2 dozes of journals including Theranositc, PNAS, Cancer Research, eLIFE, Cell Death and Differentiation, Nucleic Acid Research, Oncogene, Cell Death & Disease, Cell Reports, Molecular Cell, JBC, Molecular Cancer Research, Cell Cycle, BMC Mol Cell Biol, BMS, FEBB Letters, Frontiers, Life Science Appliance, Science China, Signal Transduction and Targeted Therapy, etc.
NIH Study Section
NIH DMP study section-standing member.
Teaching
Co-director of the Medical Grand-Round Course.
Other Service
Advisory board member for ACP (Association for Chinese Professor)-Tulane chapter New Orleans, LA (2021).
La CaTS Roadmap Fellow Applications Review Committee, New Orleans, LA (2021).
The Charity Hospital Project Plan Prereview Committee, Tulane University School of Medicine, New Orleans, LA (2021).

Diane Blake

Abstracts
Zhang, Z., Lim, L., Gilbert, C., Fan, J., Sahiner, N., Blake D., Ayyala R.S. Antimicrobial activity and biocompatibility of a hyaluronic acid-ciprofloxacin polymer. ARVO 2021, virtual, May 11, 2021.
Ayyala, R.S., Freer, K., Fullerton, M.L., Blake, D.A. Optimizing drug release in sterilized drug delivery devices to prevent post-operative fibrosis. ARVO 2021, virtual May 12, 2021.
Patent
Blake, D.A., Sun, Y. PAH Antibodies and Uses Thereof. US Patent No. 11029303, June 8, 2021.

Tony Hu

Medicine Grand Rounds, “A Golden Touch by Small Particles,” June 2nd.

Arthur Lustig

Professional Activity
Telomere Research Network Working Committee on Aging and Telomeres
Journal Reviewer
Nucleic Acids Res., Cancers (Basel), Int. Journal of Med Sci, Nature Communications
Academic Editor  Special Issues Editor
PLOS One  Micro-organisms

 

---

Congratulations to Dr. Hong Liu and his Team.  Lu Yang, Qian Zhang, Tianhua Niu, and Hong Liu (2021) SET Levels Contribute to Cohesion.  MBoC 28 Apr 2021 https://doi.org/10.1091/mbc.E20-12-0778

---

 

 

 

 

 

 

---

 

 

 

 

 

 

---

Congratulations to Dr. Hong Liu and his team on their new NIH R01 grant funding (posted 4/1/21)

Functions and Regulation of Centromeric Transcription

Abstract: The human "centromere" contains non-coding satellite DNA sequences, and its transcription is critical for maintaining chromosome stability, but its exact role remains elusive. This grant is to study how centromeric transcription promotes chromosome stability and how it is regulated.

 

 

---

 

 

 

 

 

 

 

 

 

 

 

 

 

 

---

WELCOME NEW STAFF
 

Andrea Fitte is the new Administrative Operations Manager for the Department of Biochemistry and Molecular Biology. She joined the Tulane family in July of 2018 working with Tulane University Medical Group. She was the Manager of Clinic Information & Process Training for the Tulane Doctors Medical Clinics.

Andrea obtained a BS in Health Information Management from Louisiana Tech University, an MBA from Louisiana State University Shreveport and holds a current Registered Health Information Administrator certification. She’s also an active member of the American Health Information Management Association, the Healthcare Information and Management Systems Society and Alpha Kappa Alpha Sorority, Inc.

 

Mariana A. Muravitsky was born in Moldova, grew up in Brooklyn, NY, and gradu-ated from Tulane University with a BA in Cognitive Studies and English and a minor in Russian in 2011. She gained professional experience in language services, social services, and legal and academic administration in New York City before returning to New Orleans and accepting the Project Assistant position in the Tulane Department of Chemical and Biomolecular Engineering in 2018. She is excited to take on new challenges at Tulane now as Senior Executive Secretary to Dr. Tony Hu.

In her free time, Mariana enjoys running, writing, reading (especially about theology and psychology), and spending time with friends and family. Mariana will be getting married this April and afterwards will be called Mariana Cercena.
 

---

WELCOME NEW FACULTY

The Department of Biochemistry and Molecular Biology welcomes Dr. Chenzhong Li to the ranks of new faculty in the department, with an appointment as Professor of Biochemistry and Molecular Biology on the research track, the Center of Cellular and Molecular Diagnosis.  Dr. Li comes to Tulane from the Florida International University in Miami, where he was Professor of Biomedical Engineering and Director of the Nanobioengineering/Biosensors Lab.

Dr. Li is an expert in bioinstrumentation, specifically in the development of biomedical devices for both diagnostic and therapeutic, which could have cross-applications for environmental, food safety monitoring, and homeland security. His team has successfully developed several POCT and organ on chip based sensing platforms for early diagnosis of cancer, Alzheimer's disease, infectious disease, and environmental exposure assessment. 

Dr. Li has more than 20 years of working experience as a researcher, professor, entrepreneur, and a government funding program director.   With previous working experience in all sectors including industry, government labs and academia, he is in an excellent position to understand each system’s language and priorities. This will aid him to build a strong link between Tulane, government agencies, and high-tech industries.

“I am thrilled to make use of all my experience and working with new teammates here at Tulane,” Dr. Li said.

Please welcome Dr. Chenzhong Li to our Tulane Community.
 

---

Published Articles by our Faculty – January 1^st-March 31^st, 2021
 

Bejarano, F., Chang, C.H., Sun, K., Hagen, J.W., Deng, W.M., and Lai, E.C. (2021) A comprehensive in vivo screen for anti-apoptotic miRNAs indicates broad capacities for oncogenic synergy.  Dev Biol. 2021 Mar 1;475:10-20. doi: 10.1016/j.ydbio.2021.02.010. Online ahead of print. PMID: 33662357

_______________________________________________________________

Gong, S., Zhang, Y., Bao, H., Wang, X., Chang, C.H., Huang, Y.C., and Deng, W.M. (2021) Tumor Allotransplantation in Drosophila melanogaster with a Programmable Auto-Nanoliter Injector. J Vis Exp. 2021 Feb 2;(168). doi: 10.3791/62229. PMID: 33616117

_______________________________________________________________

Row, S, Huang, Y.C., and Deng, W.M. (2021)  Developmental regulation of oocyte lipid intake through ‘patent’ follicular epithelium in Drosophila melanogaster.  iScience Apr. 2021 23;24, 4, doi.org/10.1016/j.isci.2021.102275

_______________________________________________________________

Beddingfield, B.J., Iwanaga, N., Chapagain, P.P., Zheng, W.,  Roy, C.J.,  Hu, T.Y., Kolls, J.K., and Bix, G.J. (2021) The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection.  JACC Basic Transl Sci. 2021 Jan;6(1):1-8.  doi: 10.1016/j.jacbts.2020.10.003.

_______________________________________________________________

Jain, S., Nehra, M., Kumar, R., Dilbaghi, N., Hu, T.Y., Kumar, S., Kaushik, A., and Li, C. (2021) Internet of medical things (IoMT)-integrated biosensors for point-of-care testing of infectious diseases. Biosens Bioelectron., doi: 10.1016/j.bios.2021.113074. Epub 2021 Feb 6.

_______________________________________________________________

He, Y., Lyon, C.J., Nguyen, D.T.,  Liu, C.,  Sha, W., Graviss, E.A., and Hu, T.Y. (2021)  Serum-Based Diagnosis of Pediatric Tuberculosis by Assay of Mycobacterium tuberculosis Factors: a Retrospective Cohort Study. J Clin Microbiol. 2021 Jan 21;59(2):e01756-20.  doi: 10.1128/JCM.01756-20. Print 2021 Jan 21.

_______________________________________________________________

Ning, B., Yu, T., Zhang, S., Huang, Z., Tian, D., Lin, Z., Niu, A., Golden, N., Hensley, K., Threaten, B., Lyon, C.J., Yin, X.M., Roy, C.J., Saba, N.S., Rapport, J., Wei, Q., and Hu, T.Y. (2021) A smartphone-read ultrasensitive and quantitative saliva test for COVID-19.   Sci Adv. 2021 Jan 8;7(2):eabe3703. doi: 10.1126/sciadv.abe3703. Print 2021 Jan. 

_______________________________________________________________

Huang, Z., Ning, N., Yang, H.S., Youngquist, B.M., Niu, A., Lyon, C.J., Beddingfield, B.J., Fears, A.C., Monk, C.H., Murrell, A.E., Bilton, S.J., Linhuber, J.P., Norton, E.B., Dietrich, M.L., Yee, J.K., Lai, W., Scott, J.W., Yin, W.M., Rappaport, J., Robinson, J.E., Saba, N.S., Roy, C.J.,  Zwezdaryk, K.J., Zhao, Z., and Hu, T.Y. (2021) Sensitive tracking of circulating viral RNA through all stages of SARS-CoV-2 infection. J Clin Invest. 2021 Feb 9;146031. doi: 10.1172/JCI146031. Online ahead of print.

_______________________________________________________________

Sun, D.,  Zhao, Z., Spiegel, S., Liu, Y., Fan, J., Amrollahi, P., Hu, J., Lyon, C.J., Wan, M., and Hu, T.Y. (2021) Dye-free spectrophotometric measurement of nucleic acid-to-protein ratio for cell-selective extracellular vesicle discrimination.  Biosens Bioelectron. 2021 May 1;179:113058.  doi: 10.1016/j.bios.2021.113058. Epub 2021 Feb 9.

_______________________________________________________________

Hao, Q., Chen, J., Liao, J., Huang, Y., Larisch, S., Zeng, S.X., Lu, H., and Zhou, X. (2021) p53 induces SEPT4/ARTS as a positive feedback regulator in mitochondrial apoptosis. Cell Death & Disease. 12, 204.

_______________________________________________________________

Yan, Z., Cheng, M., Hu, G., Wang, Y., Zeng, S., Huang, A., Shi, C., Deng, L., Rao, H., Lu, H., Chen, Y., and Luo, S. (2021) Positive feedback of SuFu negating protein 1 to Hedgehog signaling promotes colorectal tumorigenesis. Cell Death & Disease. 12, 199.

_______________________________________________________________

Wang, S.S., Hao, Q., Li, J.J., Chen, Y.J., Lu, H., Wu, X.H., and Zhou, X. (2021) Ubiquitin ligase DRX3 empowers mutant p53 to promote ovarian cancer development. Genes & Diseases. In press.

_______________________________________________________________

Chen, C.H., Starr, C.G., Guha, S., Wimley, W.C., Ulmschneider, M.B., and  Ulmschneider, J.P. (2021) Tuning of a Membrane-Perforating Antimicrobial Peptide to Selectively Target Membranes of Different Lipid Composition.  J Membr Biol. 2021 Feb;254(1):75-96. doi: 10.1007/s00232-021-00174-1. Epub 2021 Feb 10.PMID: 33564914

_______________________________________________________________

Kim, S.Y., Bondar, A.N., Wimley, W.C., and Hristova, K. (2021) pH-triggered pore-forming peptides with strong composition-dependent membrane selectivity. Biophys J. 2021 Feb 16;120(4):618-630. doi: 10.1016/j.bpj.2021.01.010. Epub 2021 Jan 16.PMID: 33460594

 

---

From Tulane News

Tulane develops test that can detect COVID-19 that nasal swabs miss
February 26, 2021 8:30 AM
 
Carolyn Scofield cscofiel@tulane.edu

Tulane University researchers have developed a highly sensitive blood test that can detect COVID-19 in rare cases when infections were missed by nasal swab PCR tests.

The research results were published in the Journal of Clinical Investigation.

Most PCR-based COVID-19 tests use nasal swabs because the virus actively replicates in the upper respiratory tract immediately after infection. However, virus levels in the nose wane through the course of infection. Studies have shown that the virus can be detected in blood and blood viral levels can indicate disease severity, but PCR tests aren’t sensitive enough for reliable blood screening.

Tony Hu, Weatherhead Presidential Chair in Biotechnology Innovation at Tulane University School of Medicine, developed a test that solves the issue using CRISPR gene-editing technology. His test amplifies a genetic fragment of the SARS-CoV-2 virus, similar to conventional testing assays, but then uses CRISPR to greatly amplify the signal produced in response to this target DNA region.

The test could be especially useful in clinical applications where patients may be presenting with severe symptoms of COVID-19 but consistently test negative for the disease using nasal swab PCR tests, Hu said.

“This approach could not only improve the accuracy of COVID-19 diagnoses but it may also help doctors predict the severity of infection and whether patients have fully cleared the virus,” Hu said.

Using a nonhuman primate model of asymptomatic COVID-19, Hu and his team compared the new test with PCR tests immediately after infection. SARS-CoV-2 RNA was detectable in plasma from the first day after virus exposure and remained high thereafter, unlike nasal swab levels, which steadily declined after infection.

Hu and his team also used the plasma test to screen blood samples from patients.

They detected virus RNA in 32 of 34 samples collected from symptomatic COVID-19 patients who had positive nasal swab PCR tests (91% sensitivity) and did not detect virus RNA in 124 of the 125 samples collected before the pandemic (99% specificity). PCR-based screening, however, detected virus RNA in only 44% of the blood samples from the COVID-19 patients.

Researchers also evaluated the test on samples from children and a small cohort of cancer patients. In a group of 32 children screened for COVID-19, the CRISPR-based test found three infections missed by nasal swab PCR tests. These cases were later confirmed by antibody testing. Researchers tested samples from five patients with a history of leukemia who exhibited COVID-19 symptoms, but whose nasal swab PCR tests results were negative. The CRISPR test detected COVID-19 in four of these patients.

Tulane researchers also found that COVID-19 patients who had the most serious symptoms had the highest levels of virus RNA in their blood. Understanding more about the virus can lead to better treatments for patients, Hu said.

---

Welcome New Faculty

Tulane University School of Medicine and the Department of Biochemistry and Molecular Biology are pleased to announce that Dr. Jun-Yuan Ji, currently at Texas A&M University, will join the department in March 2021 as a Full Professor. 

Dr. Ji is a developmental geneticist with research interests in cancer biology. He and his laboratory have made several important contributions to understanding transcriptional regulation of lipid metabolism and cell-cycle processes using Drosophila and cultured cancer cells as experimental systems. His active research programs have been well funded with several grants from NIH and AHA. He has contributed to a number of high quality publications in peer-reviewed journals, such as Nature, Nature Cell Biology, Genes & Development, Nature Communications, PNAS, PLoS Biology, PLoS Genetics, Journal of Clinical Investigation, and Development, Genetics. He has received several awards including the AHA NCRP Spring 2011 Scientist Development award and served as a reviewer for a number of scientific journals and federal and private funding agents. He is one of the most highly recognized scientists in the fields of cancer signaling and developmental genetics using Drosophila as a model system.

Dr. Ji graduated from Lanzhou University with a bachelor's degree in Cell Biology in 1994, and then obtained a master's degree in Developmental Biology from the Institute of Genetics and Developmental Biology at the Chinese Academy of Sciences in Beijing. After obtaining his Ph.D. degree in Zoology from the University of Washington in 2003 under the tutelage of Professor Gerold Schubiger, he pursued his postdoctoral research in Professor Nicholas Dyson’s laboratory at Massachusetts General Hospital Cancer Center. In 2009, Dr. Ji joined the College of Medicine, Texas A&M University Health Science Center as an Assistant Professor on the Tenure Track, and he was promoted to Associate Professor with tenure in 2015.

We welcome Dr. Jun-Yuan Ji to our growing number of highly accomplished researchers at Tulane School of Medicine.
 

---

Funding in the Center of Cellular and Molecular Diagnostics

DOD, Qualification of Circulating Mtb Antigens for Rapid TB Diagnosis and Treatment Monitoring, 29-Sep-19 29-Sep-22, $1,300,987

NIH (R21), Mobile based Nanoplasmonice Quantification of Mtb-derived Exosomes in Serum for Pediatric TB diagnosis, 18-Sep-19 31-Jul-21, $179,885

UCSD/NIH UCSD (R01) Y2, Identifying Individuals at Risk of Progression to Active Tuberculosis, 1-Feb-20 31-Jan-21, $15,450

UWashington/NIH Sub/U Wash NanoDisk Y2, NanoDisk-MS measured Mtb antigen peptides for TB diagnosis and treatment monitoringin HIV-infected children, 1-Mar-20 28-Feb-21, $95,675

UCSD/NIH UCSD (R01, An Antigen-Detection Blood Test for Tuberculosis 1-Jul-20 30-Jun-21, $158,661

NIH (U01), Digital Nanoplasmonic Quantification of Tumor-derived Extracellular Vesicles in Plasma Microsamples, 25-Sep-20 31-Aug-21, $630,597

U Penn/Bill & Melinda Gates Foundation, Accelerating Bovine Tuberculosis Control in Developing Countries (DFID-DF), 1-Nov-20 1-Nov-21, $110,000

---

2020 Synergy Awards, Presented December 14th, 2020

In recognition of best research paper contributed by a graduate student in the department

Karl Hodel

Karl P Hodel, Meijuan J S Sun, Nathan Ungerleider, Vivian S, Park, Leonard G Williams, David L Bauer, Victoria E Immethun, Jieqiong Wang, Zucai Suo, Hua Lu, James B McLachlan, Zachary F Pursell.  POLE Mutation Spectra Are Shaped by the Mutant Allele Identity, Its Abundance, and Mismatch Repair Status. Mol Cell. 2020 Jun 18;78(6):1166-1177.e6. doi: 10.1016/j.molcel.2020.05.012. Epub 2020 Jun 3.

In recognition of best research paper contributed by a postdoc or junior non-faculty research scientist in the department

Ji Hoon Jung

Ji Hoon Jung, Hyemin Lee, Bo Cao, Peng Liao, Shelya X  Zeng, Hua Lu.  RNA-binding motif protein 10 induces apoptosis and suppresses proliferation by activating p53.  Oncogene. 2020 Jan;39(5):1031-1040. doi: 10.1038/s41388-019-1034-9. Epub 2019 Oct 7.

Jim & Betty Karam Postdoctoral Training Endowed Fund

Congratulations to Diana Stafa (Han Lab).

Quoc C. Le MD, PhD Memorial Award 2020

Congratulations to Emma Newton (Machado lab).

In recognition of outstanding services offered by a member of the administrative staff in the department

Congratulations to Jill Barbay and Gilbert Estrada.

Special Award for Outstanding Service During the COVID-19/Coronavirus Pandemic

Congratulations to Tetyana Antoshchenko.

MILESTONE

Congratulations to Jill Barbay for 30 Years of Service to Tulane.

2020 President’s Excellence Awards

Congratulations to Jill Barbay and Laurie Miester, Team Award Recipients, School of Medicine Administrators Category.

---

Selected Recent Publications from our Faculty and their Teams, period of September 1st-December 31st, 2020

Wang, Y., Chaffee, T.S., LaRue, R.S., Huggins, D.N., Witschen, P.M., Ibrahim, A.M., Nelson, A.C., Machado, H.L., and Schwertfeger, K.L. (2020) Tissue resident macrophages promote extracellular matrix homeostasis in the mammary gland stroma of nulliparous mice. Elife; 9:e57438. (PMID: 32479261

Ibrahim, A.M., Moss, M.A., Gray, Z., Rojo, M.D., Burke, C.M., Schwertfeger, K.L., Dos Santos, C.O., and Machado, H.L. (2020) Diverse macrophage populations contribute to the inflammatory microenvironment in premalignant lesions during localized invasion. Frontiers in Oncology; 10:569985 (PMID: 33072601; PMC7541939)

Fenton, A., Elliott, E., Shahbandi, A., Ezenwa, E., Morris, C., McLawhorn, J., Jackson, J.G., Allen, P., and Murina, A. (2020) Medical students' ability to diagnose common dermatologic conditions in skin of color.  J Am Acad Dermatol. 2020 Sep;83(3):957-958. doi: 10.1016/j.jaad.2019.12.078. Epub 2020 Feb 1.PMID: 32017947 Free PMC article.

Shahbandi, A., Rao, S.G., Anderson, A.Y., Frey, W.D., Olayiwola, J.O., Ungerleider, N.A., and Jackson, J.G. (2020) BH3 mimetics selectively eliminate chemotherapy-induced senescent cells and improve response in TP53 wild-type breast cancer.  Cell Death Differ. 2020 Nov;27(11):3097-3116. doi: 10.1038/s41418-020-0564-6. Epub 2020 May 26. PMID: 32457483 Free PMC articlee.

Liu, Y., Gu, Y., Lyon, C. J., Fan, J., Koay, E., Katz, M., Han, H., Von Hoff, D., and Hu, T. (2020) Circulating levels of hydroxylated bradykinin function as an indicator of tissue HIF-1α expression. Science Bulletin. 2020,65(18): 1570-1579.

Hu, T., Walfrom, J. E., Srivastava, S. (2020) Extracellular Vesicles in Cancer Detection: Hopes and Hypes. Cell: Trends in Cancer. 2020, in press.

Huang, Z., Tian, D., Liu, Y., Lin, Z., Lyon, C., J., Lai, W., Fusco, D., Drouin, A., Yin, X., Hu, T., and Ning, B. (2020) Ultra-Sensitive High Throughput CRISPR

Diagnosis of COVID-19. Biosensors and Bioelectronics. 164:112316. [doi: 10.1016/ j.bios.2020.112316.]

He, Y., Lyon, C. J., Nguyen D. T., Liu, C., Sha, W., Graviss, E., and Hu, T. (2020) Serum-based diagnosis of pediatric tuberculosis by assay of Mycobacterium tuberculosis factors: a retrospective cohort study. J. Clin. Micro. (accepted).

Ning, B., Yu, T., Zhang, S., Huang Z, Tian D, Lin Z, Niu A, Golden N, Hensley K, Threeton B, Lyon CJ, Yin XM, Roy CH, Saba NS, Rappaport J, Wie Q, and Hu T.Y. (2020) A smartphone-read ultrasensitive and quantitative saliva test for COVID-19. Science Advances (accepted).

Galati, M.A., Hodel, K.P., Gams, M.S., Sudhaman, S., Bridge, T., Zahurancik, W.J., Ungerleider, N.A., Park, V.S., Ercan, A.B., Joksimovic, L., Siddiqui, I , Siddaway, R., Edwards, M., de Borja, R., Elshaher  D., Chung, J., Forster, V.J., Nunes, N.M,. Aronson, M., Wang, X., Ramdas, J., Seeley, A., Sarosiek, T., Dunn, G.P., Byrd, J.N., Mordechai, O., Durno, C., Martin, A., Sylien  A., Bouffet, E., Suo, Z., Jackson, J.G., Hawkins, C.E., Guidos, C.J., Purcell, Z.F., and Tabori, U. (2020) Cancers from novel Pole mutant mouse models provide insights into polymerase-mediated hypermutagenesis and immune checkpoint blockade.  Cancer Res. 2020 Sep 16:canres.0624.2020. doi: 10.1158/0008-5472.CAN-20-0624. Online ahead of print.  PMID: 32938641

Chung, J., Maruvka, Y., Subhuman, S., Kelly, J., Haradhvala, N., Bianchi, V., Edwards, M., Forster, V., Nunes, N., Galati, M., Kommas, M., Deshmukh, S., Cabric, V., Davidson, S., Zatzman, M., Light, N., Hayes, R., Brunch, M., Anderson, N., Ho, B., Hodel, K., Siddaway, R., Morrissy, A.S., Bowers, D., Larouche, V., Bronsema, A., Osborn, M., Cole, K., Opocher, E., Mason, G., Thomas, G., George, B., Ziegler, D., Lindhorst, S., Vanan, M., Yalon-Oren, M., Reddy, A., Massimino, M., Tomboc, P., Van Damme, A., Lossos, A., Durno, C., Aronson, M., Morgenstern, D., Bouffet, E., Huang, A., Taylor, M., Villani, A., Malkin, D., Hawkins, C., Purcell, Z.F., Saline, A., Dunkel, T., Getz, G., and Tabori, U. (2020)  DNA polymerase and mismatch repair exert distinct microsatellite instability signatures in normal and malignant human cells.  Cancer Discovery.  2020, in press.

Hoffmann, A.R., Guha, S., Wu, E., Grimier, J., Wang, Y., He, J., Garry, R.F., and Wimley, W.C. (2020) Broad-Spectrum Antiviral Entry Inhibition by Interfacially Active Peptides.  J Virol. 2020 Nov 9;94(23):e01682-20. doi: 10.1128/JVI.01682-20.

Wu, E., Henschke, R.M., Hristova, K., and Wimley, W.C. (2020) Rational Modulation of pH-Triggered Macromolecular Poration by Peptide Acylation and Dimerization.  J Phys Chem B. 2020 Oct 8;124(40):8835-8843. doi:10.1021/acs.jpcb.0c05363.

Liang, H., Wang, Q., Wang, D., Zheng, H., Valvakolanu, D.V., Lu, H., Wen, N., Chen, X., Xu, L., Ren, J., Guo, B., and Zhang, L. (2020) RGFP966, a Histone deacetylase 3 inhibitor, promotes glioma stem cell differentiation by blocking TGFbeta signaling via SMAD7. Biochemical Pharmacology. 114118. doi: 10.1016/j.bcp.2020.114118. Online ahead of print. PMID: 32585142.

Jung, J.H., Lee, H.M., Zeng, S.X., and Lu H. (2020) RBM10: A new regulator of p53. Cells. Invited review. 9, E2107. PMID: 32947864.

Roy, K.R., Uddin, M.B., Roy, S.C., Hill, R.A., Marshall, J., Li, Y.T., Chamcheu, J.C., Lu, H., and Liu, Y.Y. (2020) Gb3-cSrc complex in glycosphingolipid-enriched microdomains attributes to the expression of p53 mutant protein and cancer drug resistance via beta-catenin activated RNA-methylation. FASEB BioAdvances. In press.

Wang, S.S., Hao, Q., Li, J.J., Chen, Y.J., Lu, H., Wu, X.H., and Zhou, X. (2020) Ubiquitin ligase DRX3 empowers mutant p53 to promote ovarian cancer development. Genes & Diseases. In press.

 

---

 

---

 

---

CONGRATULATIONS

Congratulations to Dr. Tony Hu, North American Chinese Clinical Chemists Association Innovation in Laboratory Medicine Awardee:

Title: Mobile based Nanoplasmonic Quantification of Mtb-derived Exosomes in Serum

Project lead: Tony Y. Hu PhD, Presidential Chair Professor of Biochemistry and Molecular Biology, Director of the Center for Cellular and Molecular Diagnostics, Tulane University School of Medicine.

 

(11/02/2020)

 

---

Click to Print List of Publications (pdf)
 

---

RESEARCH

Drs. Tony Hu and Bo Ning, along with their team are putting COVID-19 testing to the test in important research taking place in the lab.

To solve the current challenges of COVID-19 testing: how to quickly identify asymptomatic infected individuals, improve testing efficiency, and help communities and universities reopen, the Hu team have developed a fast, highly sensitive, high-throughput COVID-19 nucleic acid test based on CRISPR technology. Compared to conventional RT-qPCR, this method can detect the SARS-CoV-2 in less than one hour and can be done without relying on professional equipment and personnel. Dr. Hu’s team has submitted an EUA application to the FDA with the Molecular Pathology Department. A research article based on this approach has also been published in Biosensors and Bioelectronics (https://doi.org/10.1016/j.bios.2020.112316), which is the first research article of COVID-19 at Tulane University. Right now, the group is developing this technology to extend COVID-19 diagnosis in multiple body fluids. Tulane’s hematological team has utilized the Hu lab’s CRISPR technology as a reference test in patients who are highly specious COVID-19 but showed as RT-qPCR negative. A related case report has been published by Nature Bone Marrow Transplantation (https://doi.org/10.1038/s41409-020-0972-8).

Another new technology, a smartphone-based Point-of-Care (POC) test, can detect SARS-CoV-2 in saliva within 20 minutes and provide a comprehensive result through a cellphone. This device is user friendly for individuals without lab training and useful for home testing. The manuscript of this work is now under review.

(10/9/20)
 

---

PUBLISHED ARTICLE

In June, Karl P. Hodel, Meijuan J.S. Sun, Nathan Ungerleider, Vivian S. Park, Leonard G. Williams, David L. Bauer, Victoria E. Immethun, Jieqiong Wang, Zucai Suo, Department Chair Hua Lu, James B. McLachlan, and Zachary F. Pursell had an article published in Molecular Cell (Mol. Cell. 2020 Jun 18;78(6):1166-1177.e6. doi: 10.1016/j.molcel.2020.05.012.), titled “POLE Mutation Spectra Are Shaped by the Mutant Allele Identity, Its Abundance, and Mismatch Repair Status.” (Interdisciplinary article.)

Human tumors with exonuclease domain mutations in the gene encoding DNA polymerase ε (POLE) have incredibly high mutation burdens, frequently more than 100 and even in some cases approaching 500 or more mutations per Megabase. These errors arise in four unique mutation signatures occurring in different relative amounts, the etiologies of which remain poorly understood. This team used CRISPR-Cas9 to engineer human cell lines expressing POLE tumor variants, with and without mismatch repair (MMR). Whole-exome sequencing of these cells after defined numbers of population doublings permitted analysis of nascent mutation accumulation. Unlike an exonuclease active site mutant that was previously characterized, POLE cancer mutants readily drive signature mutagenesis in the presence of functional MMR. Comparison of cell line and human patient data suggests that the relative abundance of mutation signatures partitions POLE tumors into distinct subgroups dependent on the nature of the POLE allele, its expression level, and MMR status. These results suggest that different POLE mutants have previously unappreciated differences in replication fidelity and mutagenesis.

(10/9/20)
 

---

FRUIT FLIES HELP SHED LIGHT ON TUMOR FORMATION, MIGRATION AND GROWTH

(Reprinted with permission from Inroads, June 2020)
 
A Drosophila tumor induced by Dr. Wu-Min Deng's research team helps to answer questions about how cancerous cells form, grow and metastasize. (Photo provided by Dr. Wu-Min Deng.)
 
What can the common fruit fly teach us about cancer?
 
"Over the last few decades, the fruit fly - Drosophila melanogaster - has become a successful model for studying human cancers," said Wu-Min Deng, PhD, professor of biochemistry and molecular biology and the Gerald and Flora Jo Mansfield Piltz Professor of Cancer Research.

In fact, Deng says many cancer-related genes in humans are named after genes in flies, where they were first identified, and the model is helping to shed light on how tumors form, how they migrate, and how they behave.
 
"It's not a well-known model for cancer studies, because they don’t look like humans," said Deng. "There are even oncologists who don't realize we are using a fly model for basic cancer research, but the genetic simplicity and vast arsenal of genetic tools available in Drosophila provide a unique opportunity to address questions regarding cancer initiation and progression that would be extremely challenging in other model systems."
 
The simplicity of the Drosophila model is just one of its advantages, according to Deng. While its genetic makeup is much simpler than other organisms, many of the genes and pathways involved in human disease, particularly cancer, play similar roles in the fly, making it an excellent option for biologic discovery. Their systems are easier to manipulate, allowing researchers to generate mutations and target overexpression more easily. And because their life cycle is very short and they reproduce quickly, Deng's team can induce tumors to grow within a couple of days and manipulate fly larvae to carry the same tumor as the parent.
 
The Deng Lab's recent work involving isolating Drosophila ovaries for genetic sequencing of the various cells involved in oogenesis was recently featured on the home page of the online journal PLOS Biology.
 
"We use a few different fruit fly tissues to model growth regulation and tumor formation," said Deng. "Ovary is one. Ovaries produce functional eggs for the next generation. The process is very elaborate and involves interaction between several different cell types within the organ. But the process is also regulated by other systems, so this collaboration can be analyzed. We study what kind of cells types are there, the different genes expressed, and what kinds of signaling might be involved. We feel this project will be a good resource to the field. Anyone who wants to use this model to do any type of developmental or cancer studies can refer to our paper."

Deng moved his lab to Tulane from Florida State University a little less than a year ago. Since his arrival, he has begun to explore opportunities to interact and hopefully collaborate with fellow Tulane researchers using other model systems. His team is currently working on a new manuscript looking at how cell growth is regulated normally and how disruption can lead to tumor formation in the Drosophila model. "I am very fortunate to have a group of people in my lab who have worked tirelessly to make this project possible," said Deng.

(10/9/20)

---

PUBLISHED ARTICLE

In May, Ashkan Shahbandi, Sonia G. Rao, Ashlyn Y. Anderson, Wesley D. Frey, Joy O. Olayiwola, Nathan A. Ungerleider and James G. Jackson, PhD, had an article published in Cell Death & Differentiation (Cell Death Differ. 2020 May 26. doi: 10.1038/s41418-020-0564-6), titled “BH3 mimetics selectively eliminate chemotherapy-induced senescent cells and improve response in TP53 wild-type breast cancer.”

TP53 wild-type breast tumors rarely undergo a complete pathological response after chemotherapy treatment, portending poor prognosis to patients. Studies show these tumors preferentially undergo senescence instead of apoptosis. These senescent cells persist after chemotherapy and secrete cytokines and chemokines comprising the senescence associated secretory phenotype, which promotes survival, proliferation, and metastasis. The Jackson team hypothesized that eliminating senescent tumor cells would improve chemotherapy response and extend survival. Previous studies have shown “senolytic” agents selectively kill senescent normal cells, but their efficacy in killing chemotherapy-induced senescent cancer cells is unknown. Jackson’s group showed that ABT-263, a BH3 mimetic that targets antiapoptotic proteins BCL2/BCL-XL/BCL-W, had no effect on proliferating cells, but rapidly and selectively induced apoptosis in a subset of chemotherapy-treated cancer cells, though sensitivity required days to develop. Low NOXA expression conferred resistance to ABT-263 in some cells, necessitating additional MCL1 inhibition. Gene editing confirmed breast cancer cells relied on BCL-XL or BCL-XL/MCL1 for survival in senescence. In a mouse model of breast cancer, ABT-263 treatment following chemotherapy led to apoptosis, greater tumor regression, and longer survival. Their results reveal cancer cells that have survived chemotherapy by entering senescence can be eliminated using BH3 mimetic drugs that target BCL-XL or BCL-XL/MCL1. These drugs could help minimize residual disease and extend survival in breast cancer patients that otherwise have a poor prognosis and are most in need of improved therapies.

(10/9/20)

---

RESEARCH AWARD
 
Arthur J. Lustig, PhD, and Jeffrey Cary, PhD (USDA New Orleans), received a cooperative award from the USDA, titled “Probing Chromosome Structure to Activate Silent Metabolite Gene Clusters,” beginning September 1st, 2020.
 
Aspergillus flavus, a fungus that produces oncogenic aflatoxins, contains many uncharacterized biosynthetic gene clusters.  The secondary metabolites produced by these gene clusters are currently unknown. The ARS PI will work with the cooperator to investigate the role that chromatin structure plays on the expression of secondary metabolites in the A. flavus with the goal of identifying new fungal metabolites that affect fungal fitness, pathogenicity, virulence, and toxicity.

These scientists will work with the cooperator to investigate silent or repressed secondary metabolite gene clusters in Aspergillus flavus using unique approaches that focus on altering the structure of chromosomes that could positively affect gene expression. Specifically, this team plans to activate gene clusters by inhibiting histone modifying enzymes, determine the influence of telomere position effect (TPE) on secondary metabolite production, and assess the effect of proteins that influence telomere chromatin structure and telomere length homeostasis on secondary metabolite biosynthesis.

(10/9/20)
 

---

PUBLICATION/RESEARCH

Fighting drug-resistant bacteria in the time of coronavirus

In April, the Wimley team’s paper, “Synthetic molecular evolution of host cell-compatible, antimicrobial peptides effective against drug-resistant, biofilm-forming bacteria,” was published in Proc Natl Acad Sci USA (2020 Apr 14;117[15]:8437-8448. doi: 10.1073/pnas.1918427117. Epub 2020 Apr 2.  PMID: 32241895).

The Wimley lab has been busy during the SARS2 novel coronavirus pandemic developing potential treatments for drug-resistant bacterial infections. When SARS2 inevitably fades away, these pathogens, which are a severe and growing threat to public health, will grab the world’s attention once again. In fact, as many as half of all SARS2 deaths are associated with secondary bacterial infections. In April, the Wimley lab published a long study in the Proceedings of the National Academy of Sciences describing the synthetic molecular evolution of a new family of superior antimicrobial peptides (AMPs). But the optimization of peptide antibiotics did not end there! Graduate student Jenisha Ghimire has been hard at work designing and testing rational variants of the published peptides to identify those with even better properties. Jenisha’s work has been a great success. She has created optimized peptides that have very low cytotoxicity and unprecedented, broad-spectrum antibacterial activity against a large collection of clinically isolated, multi-drug resistant human bacterial pathogens. Some of the pathogens easily killed by the optimized peptides are completely resistant to all known antibiotics and are also resistant to some known AMPs. Fortunately, the needed data had been collected before the pandemic forced us to work from home, so Jenisha spent the weeks of shutdown productively writing a new paper describing her exciting results. Dr. Wimley expects this pandemic shutdown paper to be published by the end of the year.

(10/9/20)

 

---

 

 

 

 

 

 

 

---

 

 

 

---

 

 

---

 

 

---

CONGRATULATIONS Ivana Celic, PhD, received a pilot award from Global Consortium for Reproductive Longevity and Equality (GCRLE) through the Buck Institute, entitled “LINE1 Retrotransposons in Female Reproductive Aging”, $200,000, August 1, 2020 through August 1, 2022.

 

---

CONGRATULATIONS to Jingping Liu, Meihua Wan, Tony Hu, and Christopher J. Lyon (2020) Nanomedicine therapies modulating macrophage dysfunction: a potential strategy to attenuate cytokine storms in severe infections.  Theranostics (full citation forthcoming).
 

---

Challenges of COVID-19 testing – Taking it Step by Step

Bo Ning, PhD, Research Assistant Professor, Contributing Writer

How to quickly identify COVID-19 asymptomatic infected individuals, improve testing efficiency, and help communities and universities reopen has been the challenge of the Tony Hu lab.

The Hu lab rapidly developed a fast, highly sensitive, high-throughput COVID-19 nucleic acid test based on CRISPR technology. Compared to conventional qRT-PCR, this method can detect the SARS-Cov2 in less than one hour and can be done without relying on professional equipment or personnel.

With the Molecular Pathology Department, they have submitted an EUA application to the FDA.  A research article based on this approach has been published in Biosensors and Bioelectronics (https://doi.org/10.1016/j.bios.2020.112316), which is the first research article on COVID-19 published from Tulane University. More importantly, their approach has helped doctors treat and save lives, and a related case report has been accepted by Nature Bone Marrow Transplantation.

(06/22/20)
 

---

Publications – April 1^st - May 31^st, 2020

 

The below list represents publications by faculty for the period shown above.  In the event that we omitted a publication, these may appear later with full citations.  Note that we are now indicating articles in press and accepted, due to the timely nature of the subjects they encompass. 

 

Diane Blake

 

Borjac, J., El Joumaa, M., Kawach, R., Youssef, L., and Blake, D.A. (2020) Heavy metals and organic compounds contamination in leachates collected from Deir Kanoun Ras El Ain dump and its adjacent canal in South Lebanon.  Heliyon 5 (2019) e02212.

 

Wu-Min Deng

 

Jevitt, A., Chatterjee, D., Xie, G., Wang, X.F., Otwell, T., Huang, Y.C., and Deng, W.M. (2020) A single-cell atlas of adult Drosophila ovary identifies transcriptional programs and somatic cell lineage regulating oogenesis. PLoS Biol. 2020 Apr 27;18(4):e3000538. doi: 10.1371/journal.pbio.3000538. eCollection 2020 Apr. PMID: 32339165.

 

Jia Fan and Tony Hu

 

Liu, Y., Fan, J., Xu, T., Ahmadinejad, N., Hess, K., Lin, S.H., Zhang, J., Liu, X., Liu, L., Ning, B. and Liao, Z., and Hu, T.Y. (2020) Extracellular vesicle tetraspanin-8 level predicts distant metastasis in non–small cell lung cancer after concurrent chemoradiation. Science Advances, 6(11), p.eaaz6162.

 

Sehrawat, T.S., Arab, J.P., Liu, M., Amrollahi, P., Wan, M., Fan, J., Nakao, Y., Dasgupta, D., Liao, C., Navarro-Corcuera, A., Pose, E., He, L.,  Mauer, A., Ventura-Cots, M., Bataller, R.A., Sanyal, A., J., Chalasani, N.P., Heimbach, J.K., Watt, K.D., Gores, G.J.,  Gines, P., Kamath, P.S., Simonetto, D.A., Hu, T., Shah, V H., and Malhi, H. (2020) Circulating extracellular vesicles carrying sphingolipid cargo for the diagnosis and dynamic risk profiling of alcoholic hepatitis. Hepatology. 2020, in press.

 

Liu, Y., Gu, Y., Lyon, C. J., Fan, J., Koay, E., Katz, M., Han, H., Von Hoff, D., and Hu, Y. (2020) Hypoxia-induced hydroxylated peptide in blood as predictive biomarker for prognosis of pancreatic cancer therapy. Science Bulletin. 2020, accepted.

 

Tony Hu

 

Huang, Z., Tian, D., Liu, Y., Lin, Z., Lyon, C., J., Lai, W., Fusco, D., Drouin, A., Yin, X., Hu, T., and Ning, B. (2020) Ultra-Sensitive High Throughput CRISPR Diagnosis of COVID-19. Biosensor and Bioelectronics 2020. accepted.

 

Hu, X., Liao, S., Bai, H., Gupta, S., Zhou, Y., Zhou, J., Jiao, L., Wu, L., Wang, M., Chen, X., Zhou, Y., Lu, X., Hu, T.Y., Zhang, Z., and Ying, B. (2020)  LncRNA and predictive model to improve the diagnosis of clinically diagnosed pulmonary tuberculosis.  J Clin Microbiol, 2020 Apr 15. pii: JCM.01973-19. doi: 10.1128/JCM.01973-19. [Epub ahead of print]  PMID: 32295893. 

 

Sun, D., Lyon, C., and Hu, T. (2020) Simulation-directed amplifiable nanoparticle enhanced quantitative scattering assay under low magnification darkfield microscope.  Journal of Material Chemistry B 2020, accepted.   

 

Huang, Z., Tian, D., Liu, Y., Lin, Z., Lyon, C.J., Lai, W., Fusco, D., Drouin, A., Yin, X., Hu, T., and Ning, B. (2020) Ultra-Sensitive High Throughput CRISPR Diagnosis of COVID-19. Biosensor and Bioelectronics 2020, accepted.

 

Hu, T., Frieman, M., and Walfram, J. (2020) Chloroquine against COVID-19: insights from the field of nanomedicine. Nature Nanotechnology. 2020, 15:247–249.

 

Shu, Q., Li, M., Shu, L., An, Z., Wang, J., Lv, H., Yang, M., Cai, T., Hu, T., Fu, Y., and Yang, F. (2020) Large-scale Identification of N-linked Intact Glycopeptides in Human Serum using HILIC Enrichment and Spectral Library Search. Mol Cell Proteomics. 2020, 19(4):672-689.

 

Hu, Q., Su, H., Li, J., Lyon, C., Tang, W., Wan, M., and Hu, T. (2020) Clinical Applications of Exosome Membrane Proteins. Precision Clinical Medicine. 2020, 3(1):54–66.
 

Wan, M., Wang, Y., Zhan, L., Fan, J. and Hu, T.Y. (2020) MALDI-TOF mass spectrometry-based quantification of C-peptide in diabetes patients. European Journal of Mass Spectrometry, 26(1):55-62.

 

James Jackson

 

Shahbandi, A., Rao, S.G., Anderson, A.Y., Frey, W.D., Olayiwola, J., Ungerleider, N.A., and Jackson, J.G. (2020) BH3 mimetics selectively eliminate chemotherapy-induced senescent cells and improve response in TP53 wild-type breast cancer.  Cell Death & Differentiation https://doi.org/10.1038/s41418-020-0564-6.

 

Samuel Landry

 

Cassotta, A., Paparoditis, P., Geiger, R., Mettu, R.R., Landry, S.J., Donati, A., Benevento, Foglierini, M., Lewis, D.J.M., Lanzavecchia, A., and Sallusto. F. (2020)  Deciphering and predicting CD4+ T cell immunodominance of Influenza virus hemagglutinin. Journal of Experimental Medicine, in press.

 

Hong Liu

 

Zhang, Q. and Hong L. (2020) Functioning mechanisms of Shugoshin-1 incentromeric cohesion during mitosis.  Essays in Biochemistry (2020) EBC20190077 https://doi.org/10.1042/EBC20190077.

 

Zhang, Q., Hu, L., Chen, Y., Tian, W., and Liu, H. (2020) Multisite Phosphorylation Determines the Formation of Ska-Ndc80 Macro-complexes That Are Essential for Chromosome Segregation during Mitosis. Mol Biol Cell, in press.

Hua Lu

  

Fuselier, T.T. and Lu, H. (2020) PHLD class proteins: p53-dependent and independent roles in cancer and metabolism. International Journal of Molecular Sciences. Invited review. In press.

 

Nguyen, D., Yang, K., Chiao, L., Deng, Y., Zhou, X., Zhang, Z., Zeng, S.X., and Lu, H. (2020) Inhibition of tumor suppressor p73 by nerve growth factor receptor via chaperone-mediated autophagy.  JMCB. In press. PMID:32285119.

 

Hao, Q., Wang, J.Q., Chen, Y.J., Wang, S.S., Cao, M.M., Lu, H., and Zhu, X. (2020) Dual regulation of p53 by the ribosome maturation factor SBDS. Cell Death and Disease. 11(3):197. Doi  10.1038/s41419-020-2393-4.

 

Wang, H., Liao, P., Zeng, S.X., and Lu, H. (2020). Co-targeting CDK5 and p53-R249S as a potential therapy for HCC. Cancer Biology & Therapy. 21:269-277.

 

Jung JH, Cao B, Liao P, Zeng SX, and Lu H (2020) RNA-binding protein 10 induces apoptosis and suppresses proliferation by activating p53. Oncogene. 10, 10-34-9. 2019.

 

Brown P, RELISH Consortium (..Lu H et al..), Zhou YQ (2019) Large expert-curated database for benchmarking document similarity detection in biomedical literature search. Database. 1-67. Doi: 10.1093/database/baz085.

 

Heather Machado

 

Ibrahim, A.M., Gray, Z., Gomes, A.M., Myers, L., Behbod, F., and Machado, H.L. (2020) Gas6 expression is reduced in advanced breast cancers.  NPJ Precis Oncol. 2020 Apr 24;4:9. doi: 10.1038/s41698-020-0116-z. eCollection 2020.  PMID: 32352034.

 

Zachary Pursell and Hua Lu

 

Hodel, K.P., Sun, M.J.S., Ungerleider, N., Park, V.S., Williams, L.G., Bauer, D.L., Immethun, V.E., Wang, J.Q., Suo, Z., Lu, H., McLachlan, J.B., and Pursell, Z.F. (2020) POLE Mutation Spectra Are Shaped by the Mutant Allele Identity, Its Abundance, and Mismatch Repair Status. Molecular Cell. 78:1-12, June 18, 2020.

 

William Wimley and Hua Lu

 

Liao, P., Bhattarai, N., Cao, B., Zhou, X., Jung, J.H., Damera, K., Fuselier, T.T., Thareja, S., Wimley, W.C., Wang, B., Zeng, S.X., and Lu, H.   Crotonylation at serine 46 impairs p53 activity.  Biochem Biophys Res Commun. 2020 Apr 9;524(3):730-35. doi: 10.1016/j.bbrc.2020.01.152. Epub 2020 Feb 5. PMID: 32035620.

 

William Wimley

 

Starr, C.G., Ghimire, J., Guha, S., Hoffmann, J.P., Wang, Y., Sun, L., Landreneau, B.N., Kolansky, Z.D., Kilanowski-Doroh, I.M., Sammarco, M.C., Morici, L.A., and Wimley, W.C. (2020) Synthetic molecular evolution of host cell-compatible, antimicrobial peptides effective against drug-resistant, biofilm-forming bacteria.  Proc Natl Acad Sci U S A. 2020 Apr 14;117(15):8437-8448. doi: 10.1073/pnas.1918427117. Epub 2020 Apr 2.  PMID: 32241895.

 

Wang, Y., Hoffmann, J.P., Chou, C.W., Höner Zu Bentrup, K., Fuselier, J.A., Bitoun, J.P., Wimley, W.C., and Morici, L.A. (2020)  Burkholderia thailandensis outer membrane vesicles exert antimicrobial activity against drug-resistant and competitor microbial species.  J Microbiol. 2020 Apr 11. doi: 10.1007/s12275-020-0028-1. [Epub ahead of print] PMID: 32281050.

 

 

 

---

 

---

 

---

 

---

 

 

---

 

 

 

 

---

Faculty Profiles

William Wimley - Tulane researchers discover possible pathways to treating drug-resistant infections ==> click here

Tony Hu - Tulane researchers developing rapid test for tuberculosis with DOD grant ==> click here

Tony Hu - Researchers identify marker that may predict whether lung cancer likely to spread ==> click here
 

---

Newsworthy

Our department’s Dr. Tony Hu appeared on WWL TV on Wednesday, February 26th, in the segment, “Doctors say this is not the time to panic over coronavirus:  For fact not fear, we turned to two experts at Tulane.” 

Visit:  https://www.wwltv.com/article/news/local/doctors-say-this-is-not-the-time-to-panic-over-coronavirus/289-93c50db9-3767-45d9-9e31-5f1535c9e910

 

---

Canceled due to the COVID-19 Pandemic - May 8, 2020, ZhiJian "James" Chen, PhD

---

Congratulations to Dr. Jeffrey Han, School of Medicine Bridge Funding Program, January 2020

---

 

---

 

---

 

---

 

 

 

---

Paper gets picked up by the Scientific American

Congratulations to Drs. James Jackson and Crystal Tonnessen-Murray.  Their paper,  “Chemotherapy-induced senescent cancer cells engulf other cells to enhance their survival,” which was published in the September 2019 issue of the Journal of Cell Biology, was picked up by the Scientific American.

 

---

Reprinted from Tulane News
 

Cancer cells turn to cannibalism to survive chemotherapy

September 18, 2019 7:45 AM
Keith Brannon kbrannon@tulane.edu

This video shows a doxorubicin-treated senescent breast cancer cell (green) engulfing a neighboring cancer cell (red). Video by Tonnessen-Murray et al., 2019

Researchers from Tulane University School of Medicine have discovered that some cancer cells survive chemotherapy by eating their neighboring tumor cells. The study, which was published in the Journal of Cell Biology, suggests that this act of cannibalism provides these cancer cells with the energy they need to stay alive and initiate tumor relapse after the course of treatment is completed. Read More

---

 

Publications, January 1st – March 31st, 2019

The below list represents publications by faculty for the first quarter of 2019. 

David Franklin

Martel, J.L. and Franklin, D.S.  (2019) Vitamin B1 (Thiamine). StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2019 Jan 26.

James Jackson

Shahbandi, A. and Jackson, J.G. (2019) Analysis across multiple tumor types provides no evidence that mutant p53 exerts dominant negative activity.  NPJ Precis Oncol. 2019 Jan 7;3:1. doi: 10.1038/s41698-018-0074-x. eCollection 2019.

Samuel Landry

Moss, D.L., Park, H.W., Mettu, R.R., and Landry, S.J. (2019) Deimmunizing substitutions in pseudomonas exotoxin domain III perturb antigen processing without eliminating T-cell epitopes.  J Biol Chem. 2019 Jan 25. pii: jbc.RA118.006704. doi: 10.1074/jbc.RA118.006704. [Epub ahead of print]

Hong Liu

Hu, L., Huang, H., Hei, M., Yang, Y., Li, S., Liu, Y., Dou, Z., Wu, M., Li, J., Wang, G.Z., Yao, X., Liu, H., He, X., and Tian, W. (2019) Structural analysis of fungal CENP-H/I/K homologs reveals a conserved assembly mechanism underlying proper chromosome alignment.  Nucleic Acids Res. 2019 Jan 10;47(1):468-479. doi: 10.1093/nar/gky1108.

Hua Lu

Wang, H., Liao, P., Zeng, SX., and Lu, H.  It Takes a Team: A Gain-of-function Story of p53-R249S.  J Mol Cell Biol. 2019 Jan 4. doi: 10.1093/jmcb/mjy086. [Epub ahead of print]

Arthur Lustig

Lustig, A.J. (2019)  Towards the Mechanism of Yeast Telomere Dynamics.  Trends Cell Biol. 2019 Feb 11. pii: S0962-8924(19)30006-6. doi: 10.1016/j.tcb.2019.01.005. [Epub ahead of print] Review.

Tianhua “Tim” Niu

Qin, H., Niu, T., and Zhao, J. (2019) Identifying Multi-Omics Causers and Causal Pathways for Complex Traits.  Front Genet. 2019 Feb 21;10:110. doi: 10.3389/fgene.2019.00110. eCollection 2019.

Hee-Won Park

Moss, D.L., Park, H.W., Mettu, R.R., and Landry, S.J. (2019)  Deimmunizing substitutions in pseudomonas exotoxin domain III perturb antigen processing without eliminating T-cell epitopes.  J Biol Chem. 2019 Jan 25. pii: jbc.RA118.006704. doi: 10.1074/jbc.RA118.006704. [Epub ahead of print]

Zachary Pursell

Park, V.S. and Pursell, Z.F. (2019) POLE proofreading defects: Contributions to mutagenesis and cancer.  DNA Repair (Amst). 2019 Apr;76:50-59. doi: 10.1016/j.dnarep.2019.02.007. Epub 2019 Feb 16. Review.

William Wimley

Chen, C.H., Starr, C.G., Troendle, E., Wiedman, G., Wimley, W.C., Ulmschneider, J.P., and Ulmschneider, M.B.  (2019)  Simulation-Guided Rational de Novo Design of a Small Pore-Forming Antimicrobial Peptide.  J Am Chem Soc. 2019 Mar 13. doi: 10.1021/jacs.8b11939. [Epub ahead of print]

Gerlach, S.L., Chandra, P.K., Roy, U., Gunasekera, S., Göransson, U., Wimley, W.C., Braun, S.E., and Mondal, D.  (2019) The Membrane-Active Phytopeptide Cycloviolacin O2 Simultaneously Targets HIV-1-infected Cells and Infectious Viral Particles to Potentiate the Efficacy of Antiretroviral Drugs.  Medicines (Basel). 2019 Feb 28;6(1). pii: E33. doi: 10.3390/medicines6010033.

Guha, S., Ghimire, J., Wu, E., and Wimley, W.C.  (2019) Mechanistic Landscape of Membrane-Permeabilizing Peptides.  Chem Rev. 2019 Jan 9. doi: 10.1021/acs.chemrev.8b00520. [Epub ahead of print]

Kim, S.Y., Pittman, A.E., Zapata-Mercado, E., King, G.M., Wimley, W.C., Hristova, K. (2019) Mechanism of action of peptides that cause pH-triggered macromolecular poration of lipid bilayers.  J Am Chem Soc. 2019 Mar, in press.

(03/21/19)
 

---

18th Annual George Adrouny Lecture takes place May 10th

The Department of Biochemistry and Molecular Biology is proud to present the 18th Annual George Adrouny Memorial Lectureship on Friday, May 10th, 2019, at 9:30am in the 1st Floor Auditorium of the Tulane University School of Medicine, 1430 Tulane Avenue.

---

(03/08/19)

---

(03/08/19)

---

UPDATE:  One Year Masters Students

By David Franklin, PhD

Here is an update of the One-Year MS stats, and where our Graduates stand with respect to reaching their ultimate goals.
 
We have a 100% graduation rate of 75 students since 2012. This obviously does not include our 28 present MS students.
 
88% of our graduates got accepted into at least 1 professional school of their choice (allopathic medicine, osteopathic medicine, dental, veterinary, law, nursing). Many had multiple offers of acceptance. Corey Carney has the record, with over 11 interviews and at least 5 acceptances. I think we should highlight Corey sometime soon, but after he picks which school he will attend in the Fall. I believe Tulane is still in the running.
 
7% of our graduates used their degree to get into the workforce and are gainfully employed. These were generally students who didn’t perform academically in the MS program to a level that would allow me to mentor them for medical school admissions. I instead advised them to use the degree in another fashion, which they did.
 
5% of our graduates are applying, and have been in at least 1 full admissions cycle. I am hopeful that each can get acceptance soon.
 
Not included in these numbers are graduates who have not yet had at least one full admissions cycle. They also don’t include our 28 present MS students.
 
Our MS graduates have been accepted to: Tulane School of Medicine (including one in the PSP program), LSUHSC (New Orleans and Shreveport), LSU School of Veterinary Medicine, LSU School of Dentistry, LSU School of Nursing, University of Queensland / Ochsner Program, Meharry School of Medicine, University of Illinois College of Medicine, University of South Carolina Medicine, University of Southern Alabama, Geisinger Commonwealth School of Medicine, Virginia Commonwealth University School of Medicine, University of South Florida Morsani School of Medicine, University of South Alabama Medical School, University of Miami Miller School of Medicine, Texas A&M College of Medicine, Texas Tech University School of Medicine, Mercer University School of Medicine, University of Arkansas for Medical Sciences Medical School, University of Mississippi Medical Center, University of New England School of Osteopathic Medicine, and Touro University Nevada School of Osteopathic Medicine.
 
(02/22/19)
 

---

SYNERGY 2018 EVENT A MEMORABLE OCCASION

A quack, a queen and a trip around the moon were part of the highlights of this year’s Department of Biochemistry and Molecular Biology (DBMB) Departmental 7th Annual Academic Synergy (AAS) Retreat, held December 12th in Room 111A of the J. Bennett Johnston Building. 

This event was somewhat of a homecoming for former department professor Dr. William Baricos, who retired in 2002.  Dr. Baricos presented a lecture entitled “A quack, a queen and a trip around the moon”, featuring some of our more interesting and colorful chairs from the past.

Following retirement Dr. Baricos researched and wrote Biochemistry at Tulane Medical School: 1834-2010.  This informative history spans the early years of the university, then know as the Medical College of Louisiana.

In addition to the lecture, department chair Dr. Hua Lu provided a review of 2018, giving statistics for the year and many of the highlights, such as the annual retreat and accomplishments in the department.

Over 100 guests attended this year’s annual event and partook of luncheon fare from Cottage Catering, including a “TU” shaped King cake in Tulane colors.

(12/24/18)

---

Special Lifetime Recognition

Congratulations to Dr. Hua Lu, Professor and Chair in the Department of Biochemistry and Molecular Biology, AAAS Honors Accomplished Scientist as a 2018 Elected Fellow.  The American Association for the Advancement in Science has bestowed upon 416 of its members the lifetime honor of being elected a Fellow in recognition of their extraordinary achievements in advancing science.

On November 27th the Fellows announced that honorees will be recognized at the 2019 AAAS Annual Meeting in Washington, DC, during a Fellows Forum on February 16th.  At that time they will be presented with an official certificate and the AAAS Fellows’ gold and blue rosette pin, the colors which represent their respective fields of science or engineering.

(12/24/18)

---

Jill Barbay receives President’s Staff Excellence Award

Congratulations to Senior Department Administrator Jill Barbay, winner of the Tulane President’s Staff Excellence Award for 2018.  The award was presented by Tulane President Michael Fitts in Jill’s office at the School of Medicine.

The President’s Staff Excellence Awards are bestowed every year to top University staff employees who best represent high achievement in their contributions to the University.  Those nominated will have achieved outstanding success in one or more of the following areas: Increased Productivity, Cost Savings, Enhanced Objectives, and Humanitarianism.

(12/24/18)

---

Publications, September 1st, 2018 - December 31st, 2018

The below list represents publications by faculty for the period September 1st-December 31st, 2018. 

Blake, Diane, PhD

Quesada-González, D., Jairo, G.A., Blake, R.C. 2nd, Blake, D.A., and Merkoçi, A. (2018) Uranium (VI) detection in groundwater using a gold nanoparticle/paper-based lateral flow device.  Sci Rep. 2018 Nov 1;8(1):16157. doi: 10.1038/s41598-018-34610-5

Sahiner, N., Sagbas, S., Sahiner, M., Blake, D,A., and Reed, W.F.  (2018) Polydopamine particles as nontoxic, blood compatible, antioxidant and drug delivery materials.  Colloids Surf B Biointerfaces.  2018 Sep 11;172:618-626. doi: 10.1016/j.colsurfb.2018.09.019. [Epub ahead of print]

Sahiner, M., Sahiner, N., Sagbas. S., Fullerton, M.L., and Blake, D.A. (2018) Fabrication of biodegradable poly(naringin) particles with antioxidant activity and low toxicity. ACS Omega, in press.

Jackson, James, PhD; Niu, Tianhua, PhD

Ungerleider, N.A., Rao, S.G., Shahbandi, A., Yee, D., Niu, T., Frey,  W.D., Jackson, J.G. (2018)  Breast cancer survival predicted by TP53 mutation status differs markedly depending on treatment.  Breast Cancer Res. 2018 Oct 1;20(1):115. doi: 10.1186/s13058-018-1044-5.

Shahbandi, A. and Jackson, J.G. (2018) Analysis across multiple tumor types provides no evidence that mutant p53 exerts dominant negative activity.   NPJ Precision Oncology, in press.

Liu, Hong, PhD

Hu, L., Huang, H., Hei, M., Yang, Y., Li, S., Liu, Y., Dou, Z., Wu, M., Li, J., Wang, G.Z., Yao, X., Liu, H., He, X., and Tian W. (2018) Structural analysis of fungal CENP-H/I/K homologs reveals a conserved assembly mechanism underlying proper chromosome alignment. Nucleic Acids Res. 2018 Nov 8. doi: 10.1093/nar/gky1108. [Epub ahead of print]

Lu, Hua, MB, PhD

Lu, H. (2018) New players critical for breast cancer.  J Mol Cell Biol. 2018 Aug 1;10(4):271-272. doi: 10.1093/jmcb/mjy046.

Wang, H., Liao, P., Zeng, S.X., and Lu, H. (2018). It takes a team: Gain- of-function Story of p53-R249S. JMCB, in press.

Machado, Heather, PhD

Nelson, A.C., Machado, H.L., and Schwertfeger, K.L. (2018) Breaking through to the Other Side: Microenvironment Contributions to DCIS Initiation and Progression. J Mammary Gland Biol Neoplasia. 2018 Aug 31. doi: 10.1007/s10911-018-9409-z. [Epub ahead of print] Review.

Behbod, F., Gomes, A.M., and Machado, H.L.(2018) Modeling Human Ductal Carcinoma In Situ in the Mouse.  J Mammary Gland Biol Neoplasia. 2018 Aug 25. doi: 10.1007/s10911-018-9408-0. [Epub ahead of print].

(12/24/18)

---

Newsworthy

Congratulations to Dr. Hong Liu, recipient of an Outstanding Achievement in Receiving a First R01 Award, at the SOM Faculty Retreat, Audubon Tea Room, October 30th, 2018.

Congratulations to Shantanu Guha, who won Best Overall Presentation at the Annual BMS Retreat, held at the Audubon Tea Room, October 26th, 2018.

Congratulations to Zane Gray, Research Tech in the Machado Lab, accepted to Tulane School of Medicine.

(12/24/18)

---

Milestones

Congratulations to the following members of the department who are celebrating milestone anniversaries at Tulane.

Diane Blake, PhD
25 Years

Gilbert Estrada
25 Years

Samuel Landry, PhD
25 Years

William Wimley, PhD
20 Years

(12/24/18)